Sarepta Therapeutics Inc (NASDAQ:SRPT)
| 130.19 Delayed Data As of Mar 24 |  +1.81 / +1.41%Today’s Change | 61.28 Today|||52-Week Range 159.84 | +0.47% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 1.3M | 5.4M | 154.6M | 301.0M | |
| Cost of Goods Sold | -- | 130.0K | 314.0K | 22.8M | ||
| Depreciation And Amortization | 5.2M | 5.6M | 8.1M | 12.2M | ||
| Operating Expenses | Gross Income | -- | -320.0K | 146.2M | 266.0M | |
| General Expenses | 207.0M | 261.8M | 282.8M | 607.9M | ||
| Research And Development | 146.4M | 186.3M | 166.5M | 397.9M | ||
| Total Operating Expenses | 212.3M | 267.6M | 291.2M | 643.0M | ||
| Non-Operating Expenses | Operating Income | -211.0M | -262.2M | -136.7M | -342.0M | |
| Extraordinary Credit | 0.00 | 0.00 | 125.0M | 2.2M | ||
| Extraordinary Charge | -9.2M | -4.6M | -35.0M | -6.2M | ||
| Interest Expense On Debt | -- | 535.0K | 5.8M | 33.7M | ||
| Other Expenses | 0.00 | 0.00 | 2.0M | 1.7M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -220.0M | -267.3M | -48.6M | -362.6M | |
| Income Taxes | 0.00 | 0.00 | -2.1M | -692.0K | ||
| Net Income | -220.0M | -267.3M | -50.7M | -361.9M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 42.3M | 48.7M | 58.8M | 66.3M | |
| Shares To Calculate EPS Diluted | 42.3M | 48.7M | 58.8M | 66.3M | ||
| Earnings Per Share | EPS | -$5.20 | -$5.49 | -$0.86 | -$5.46 | |
| EPS Diluted | -$5.20 | -$5.49 | -$0.86 | -$5.46 | ||
